Alpha 2-adrenergic sensitivity in Parkinson's disease.
Berlan
M
M
Laboratoire de Pharmacologie Médicale et Clinique, INSERM U 317, CHU, Faculté de Médecine, Toulouse, France.
Rascol
O
O
Belin
J
J
Moatti
J P
JP
Rascol
A
A
Montastruc
J L
JL
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D003000:Clonidine / Q000494:pharmacology*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000097:blood / Q000503:physiopathology*; D011942:Receptors, Adrenergic, alpha / Q000502:physiology*
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D011942:Receptors, Adrenergic, alpha; D013006:Growth Hormone; D003000:Clonidine